APP and Alzheimer disease: Inhibiting CSF1R in AD mouse models (including APPswe [88], PSEN1dE9 [89], APP/PS1 [88], and 5xfAD mice [90]) decreases the proliferation of microglia and rescues behavioral deficits [87, 91].